Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.

Journal of inherited metabolic disease - 1 Oct 2010

Hale Jaime E, Parad Richard B, Dorkin Henry L, Gerstle Robert, Lapey Allen, O'Sullivan Brian P, Spencer Terry, Yee William, Comeau Anne Marie

Abstract excerpt

Newborn screening (NBS) for cystic fibrosis (CF) offers the opportunity for early diagnosis and improved outcomes in patients with CF and has been universally available in the state of Massachusetts since 1999 using an immunoreactive trypsinogen (IRT)-DNA algorithm. Ideally, CF NBS is incorporated as part of an integrated NBS system that allows for comprehensive and coordinated education, laboratory screening,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chlorides
Share to Immunoassay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Massachusetts

Share to Neonatal Screening

Share to Primary Health Care

Share to Program Evaluation

Share to Trypsinogen

Source

Identifiers

PMID: 20521170
DOI: 10.1007/s10545-010-9117-3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.PMID 20521170Read ↗

Improving outcomes for Colorado's IRT-IRT-DNA cystic fibrosis newborn screening algorithm by implementing floating cutoffs.Semantic proximity Read ↗

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.Semantic proximity Read ↗

A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.Semantic proximity Read ↗

Refinement of newborn screening for cystic fibrosis with next generation sequencing.Semantic proximity Read ↗

Utility of a very high IRT/No mutation referral category in cystic fibrosis newborn screening.Semantic proximity Read ↗

Genomic sequencing in cystic fibrosis newborn screening: what works best, two-tier predefined CFTR mutation panels or second-tier CFTR panel followed by third-tier sequencing?Semantic proximity Read ↗

REFINEMENT OF NEWBORN SCREENING FOR CYSTIC FIBROSIS WITH NEXT GENERATION SEQUENCINGSemantic proximity Read ↗

Variation in cystic fibrosis newborn screening algorithms in the United States.Semantic proximity Read ↗

Four-year evaluation of neonatal cystic fibrosis screening in Southern Belgium.Semantic proximity Read ↗

Improving the Sensitivity and Positive Predictive Value in a Cystic Fibrosis Newborn Screening Program Using a Repeat Immunoreactive Trypsinogen and Genetic Analysis.Semantic proximity Read ↗

Screening for cystic fibrosis in New York State: considerations for algorithm improvements.Semantic proximity Read ↗

Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.